Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health, Inc. (OSCR) on Tuesday cut its full-year financial guidance and provided second-quarter (Q2) earnings estimates ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Oscar Health (OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook.

Oscar Health (OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook.

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 ...

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...